Sponsor Pipeline

The Aurum Institute NPC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
1
Phase 3
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06511180
Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a…		 overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT05515042
Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in…		 overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 4
1
Phase 2/3
1
Phase 1/2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05118490 Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To… HIV Seropositivity Active, Not Recruiting
Phase 2/3
NCT05686356 A Pan-TB Regimen Targeting Host and Microbe Tuberculosis Active, Not Recruiting
Phase 1/2
NCT05122026 Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and… HIV Seropositivity Active, Not Recruiting
NCT05122767 Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking… Tuberculosis Active, Not Recruiting
Not specified
NCT06909799 A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease Tuberculosis (TB) Recruiting
Get alerts when The Aurum Institute NPC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free